Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
Condition(s):Solid Tumor, AdultLast Updated:March 6, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Solid Tumor, AdultLast Updated:March 6, 2024Recruiting
Condition(s):MalnutritionLast Updated:January 29, 2018Completed
Condition(s):Individuals at Risk of Zinc DeficiencyLast Updated:March 22, 2018Completed
Condition(s):Anemia; MalnutritionLast Updated:March 27, 2017Completed
Condition(s):MalnutritionLast Updated:February 23, 2017Completed
Condition(s):Infant Malnutrition; Malnutrition in PregnancyLast Updated:November 29, 2023Active, not recruiting
Condition(s):Exclusive Breastfeeding; Feeding Patterns; Stunting; Obesity, ChildhoodLast Updated:March 9, 2022Withdrawn
Condition(s):Anemia; Malnutrition; StuntingLast Updated:February 24, 2022Completed
Condition(s):MalnutritionLast Updated:May 30, 2017Completed
Condition(s):Exclusive Breast Feeding; Feeding Patterns; Stunting; Obesity, ChildhoodLast Updated:March 9, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.